Calliditas Therapeutics to Attend Investor Conferences in March
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”), a commercial biopharma company focused on rare diseases today announced that Renee Aguiar-Lucander, CEO of Calliditas will participate in the following March 2024 conferences. Carnegie Healthcare Seminar, Wednesday, March 6, 2024. Fireside chat will be held at 10:20 – 10:50 am CET and one-on-one meetings will be available. Jefferies Biotech on the Bay Summit, Wednesday, March 13, 2024 in Miami, FL, one-on-one meetings will be available. Leerink Partners Global Biopharma Conference on March 12,